BillionToOne Inc., a molecular diagnostics company, has announced its initial public offering and will begin trading on the Nasdaq Global Select Market on November 6, 2025, under the ticker symbol "BLLN".
In the offering, the company will be issuing 4.55 million shares of its Class A common stock at $60 per share. The offering is scheduled to close on November 7, 2025, and is expected to generate gross proceeds of $273.1 million.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com